-
Panelists discuss ongoing progress toward precision medicine in diabetes
The promise of treatment informed by patient genetics continues to grow for people living with monogenic diabetes, type 1 diabetes, type 2 diabetes, and gestational diabetes. One ongoing barrier in the U.S. is lack of insurance coverage for genetic testing, said Rochelle N. Naylor, MD, part of a panel on the international Precision Medicine in…
-
Design and engineering can inform diabetes quality teams
Designers and engineers play a role in the effectiveness and usability of diabetes technology, and three experts, including Wendy Rogers, PhD, gathered for a panel discussion about quality teams and what they can learn from design and engineering processes. Dr. Rogers outlined a framework for designing technology that supports patients from diagnosis to sustained self-care.
-
ICYMI Presenter Profile: Do-It-Yourself (DIY) vs. Commercial Closed-Loop Systems for Managing Type 1 Diabetes
Dana M. Lewis gives an overview of a Professional Interest Group discussion held at the 83rd Scientific Sessions. She helped develop the first open-source automated insulin delivery system.
-
ICYMI Presenter Profile: What Is the Best Approach to the Management of Painful Diabetic Neuropathy?
Lance M. McCracken, PhD, who studies stress responses and blood glucose in diabetes, previews a Professional Interest Group discussion held at the 83rd Scientific Sessions. Registered participants can view select recordings, including of this session, on the meeting’s virtual platform through August 28.
-
Investigators share new findings in islet cell interactions
Pancreatic islets contain five endocrine cell types that interact with each other and the rest of the body. Scientists shared their latest research into the islet-cell interactome during the 83rd Scientific Sessions. Maria L. Golson, PhD, explored the mechanisms by which delta cells regulate beta cell function. Delta cells are known primarily for their production…
-
Experts debate role of the microbiome in obesity
The microbiome accounts for 99% of the genes in a human, yet the notion that the microbiome plays a role in human obesity is all hype, according to Max Nieuwdorp, MD, PhD. He debated Rob Knight, PhD, on this issue. Dr. Knight supported the argument that the microbiome is key in obesity.
-
Symposium compares models for unlocking the mechanisms of obesity
James D. Johnson, PhD, and Kevin D. Hall, PhD, discussed the scientific merit of and the hypotheses driving the two leading models for understanding obesity: the carbohydrate-insulin model and the energy-balance model.
-
ICYMI Presenter Profile: Updates in Diabetes and Fasting
Mohamed M. Hassanein, FRCP, CCST UK, previews a presentation at the 83rd Scientific Sessions. Registered participants can view select recordings, including of this session, on the meeting’s virtual platform through August 28.
-
Researchers investigate physical activity considerations for older adults with diabetes
A panel of experts analyzed the effects of physical activity on older adults with diabetes to determine potential therapeutic interventions. Bruce A. Perkins, MD, MPH, discussed his research into longevity in type 1 diabetes and the benefits physical activity has on beta-cell reserve.
-
Session examines how to reduce hypoglycemia at patient and system levels
In the U.S. alone, the direct cost of hospitalization for severe hypoglycemia tops $1.8 billion, reported Alexandria Ratzki-Leewing, PhD, in a session that offered a detailed look at the challenges hypoglycemia causes for older people living with diabetes, including health outcomes and financial burdens.